The company’s main LadyCare product provides significant relief for symptoms of menopause, used by half a million UK women in the UK alone. Annual sales surpassed £1 million, with 50% EBITDA, prior to the pandemic, but sales are presently running at approximately £300,000 per annum, with 40% EBITDA,40% on Amazon and 60% via the company website.
There is proven interested from new retail channels in the UK, the US (at one point, sales there approached $1 million per annum), and internationally. The offering consists of a product portfolio (addressing period pain and male sexual health, in addition to menopause), patents, trademarks and other intellectual property, including a significant body of research offer insights into the mechanisms underlying a number of human health and wellness issues, as well as significant stock, and equipment for product assembly and packaging. The inventor-owner wishes to retire, though with full commitment to a successful transition and potential ongoing shareholding.
Why register with Rightbiz?